✦ LIBER ✦

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil.

✍ Scribed by S Negrier; A Caty; T Lesimple; Douillard J-Y; B Escudier; Rossi J-F; P Viens; F Gomez

Book ID: 117724168
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(01)00164-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MONOTHERAPY WITH INTERFERON-α, OR COMBIN

MONOTHERAPY WITH INTERFERON-α, OR COMBINATION THERAPY WITH INTERFERON-α, INTERLEUKIN-2 AND 5-FLUOROURACIL FOR METASTATIC RENAL CELL CARCINOMA

✍ Park, Y.H.; Jeong, C.W.; Hong, S.K.; Jeong, H.; Kwak, C.; Lee, S.E.; Lee, E. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Outpatient treatment with subcutaneous i

Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience

✍ G. Marx; J. Taylor; D. Goldstein 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Recombinant interferon alfa-2a with or w

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma

✍ Sophie D. Fossåu; Stephen T. De Garis; Mona S. Heier; Asbjøsrn Flokkmann; Hans H 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Phase I and II trials of subcutaneously

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

✍ T. Olencki; D. Peereboom; L. Wood; G. T. Budd; A. Novick; J. Finke; D. McLain; P 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 103 KB

Treatment of renal cell carcinoma with 5

Treatment of renal cell carcinoma with 5-fluorouracil and alfa-interferon

✍ Norman P. Gebrosky; Stephen Koukol; Unyime O. Nseyo; Cindy Carpenter; Donald L. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 618 KB

A Phase II trial of intravenous gemcitab

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH